| Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus … EH Romond, JH Jeong, P Rastogi, SM Swain, CE Geyer Jr, MS Ewer, ... Journal of Clinical Oncology 30 (31), 3792-3799, 2012 | 578 | 2012 |
| Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled … AHG Paterson, SJ Anderson, BC Lembersky, L Fehrenbacher, CI Falkson, ... The lancet oncology 13 (7), 734-742, 2012 | 209 | 2012 |
| Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43 KP Siziopikou, SJ Anderson, MA Cobleigh, TB Julian, DW Arthur, P Zheng, ... Breast cancer research and treatment 142, 415-421, 2013 | 83 | 2013 |
| An examination of claims-based predictors of overdose from a large Medicaid program G Cochran, AJ Gordon, WH Lo-Ciganic, WF Gellad, W Frazier, C Lobo, ... Medical care 55 (3), 291-298, 2017 | 71 | 2017 |
| Magnetic sphincter augmentation and postoperative dysphagia: characterization, clinical risk factors, and management S Ayazi, P Zheng, AH Zaidi, K Chovanec, N Chowdhury, M Salvitti, ... Journal of Gastrointestinal Surgery 24 (1), 39-49, 2020 | 64 | 2020 |
| Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group PA Ganz, SR Land, C Antonio, P Zheng, G Yothers, L Petersen, ... Journal of Cancer Survivorship 3, 137-147, 2009 | 54 | 2009 |
| Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01 H Kunitake, MM Russell, P Zheng, G Yothers, SR Land, L Petersen, ... Journal of Cancer Survivorship 11, 111-118, 2017 | 46 | 2017 |
| S2-3: NSABP Protocol B-34: A Clinical Trial Comparing Adjuvant Clodronate vs. Placebo in Early Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Tamoxifen or … AHG Paterson, SJ Anderson, BC Lembersky, L Fehrenbacher, CI Falkson, ... Cancer Research 71 (24_Supplement), S2-3-S2-3, 2011 | 40 | 2011 |
| Clinical outcomes and predictors of favorable result after laparoscopic magnetic sphincter augmentation: single-institution experience with more than 500 patients S Ayazi, P Zheng, AH Zaidi, K Chovanec, M Salvitti, K Newhams, T Hoppo, ... Journal of the American College of Surgeons 230 (5), 733-743, 2020 | 38 | 2020 |
| Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence S Ayazi, N Chowdhury, AH Zaidi, K Chovanec, Y Komatsu, AN Omstead, ... Surgical Endoscopy 34, 1835-1846, 2020 | 30 | 2020 |
| Medicaid prior authorization and opioid medication abuse and overdose G Cochran, AJ Gordon, WF Gellad, CCH Chang, WH Lo-Ciganic, C Lobo, ... The American journal of managed care 23 (5), e164, 2017 | 30 | 2017 |
| Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model AH Zaidi, RJ Kelly, A Gorbunova, AN Omstead, MS Salvitti, P Zheng, ... Oncotarget 12 (4), 292, 2021 | 26 | 2021 |
| Prescription opioid quality measures applied among Pennsylvania Medicaid enrollees G Cochran, WH Lo-Ciganic, WF Gellad, AJ Gordon, E Cole, C Lobo, ... Journal of managed care & specialty pharmacy 24 (9), 875-885, 2018 | 17 | 2018 |
| Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01 H Kunitake, P Zheng, G Yothers, SR Land, L Fehrenbacher, JK Giguere, ... Journal of clinical oncology 28 (36), 5274-5279, 2010 | 17 | 2010 |
| Measurement of outflow resistance imposed by magnetic sphincter augmentation: defining normal values and clinical implication S Ayazi, AD Grubic, P Zheng, AH Zaidi, K Schwameis, AC Alleyne, ... Surgical Endoscopy 35, 5787-5795, 2021 | 15 | 2021 |
| The impact of magnetic sphincter augmentation (MSA) on esophagogastric junction (EGJ) and esophageal body physiology and manometric characteristics S Ayazi, K Schwameis, P Zheng, K Newhams, BM Myers, AD Grubic, ... Annals of Surgery 277 (3), e545-e551, 2023 | 13 | 2023 |
| CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model AN Omstead, M Paskewicz, A Gorbunova, P Zheng, MS Salvitti, ... Carcinogenesis 43 (9), 842-850, 2022 | 13 | 2022 |
| Efficacy of magnetic sphincter augmentation across the spectrum of GERD disease severity K Schwameis, S Ayazi, P Zheng, AD Grubic, M Salvitti, T Hoppo, BA Jobe Journal of the American College of Surgeons 232 (3), 288-297, 2021 | 13 | 2021 |
| Comparison of surgical payer costs and implication on the healthcare expenses between laparoscopic magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication … S Ayazi, AH Zaidi, P Zheng, K Chovanec, N Chowdhury, M Salvitti, ... Surgical Endoscopy 34, 2279-2286, 2020 | 11 | 2020 |
| Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma L Babar, JE Kosovec, V Jahangiri, N Chowdhury, P Zheng, AN Omstead, ... Oncotarget 10 (44), 4546, 2019 | 11 | 2019 |
